ETON Stock Catalyst: Eton Pharmaceuticals Expects FY2026 Revenue to Exceed $145.000M

Aug 13, 2026 · 4:07pm ET

Company anticipates significant revenue growth in the next fiscal year.

Max move

+46.5%

High of day $59.79

Sparker timei

4:07pm ET

ETON · Aug 13, 2026

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Eton Pharmaceuticals, Inc. (Nasdaq: ETON) announced its expectation for fiscal year 2026 revenue to surpass $145.000 million. This projection reflects the company's optimistic outlook on its financial performance.

The anticipated revenue of $145.000 million for FY2026 represents an increase from the $121.326 million reported for the previous fiscal year. The company did not provide a direct comparison or specific growth rate.

As of the latest data, Eton Pharmaceuticals has a free float of 21,048,562 shares and 27,392,358 shares outstanding.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time ETON sparks.

Download Sniper App →

Catch the next ETON-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →